Hedge funds experienced a sudden increase in complex and intense cyberattacks in 2023. According to Agio, companies that brought their cyber programs in-house saw significant increase: 77% noted a ...

The consensus price target hints at a 26% upside potential for Agios Pharmaceuticals (AGIO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...

If April 23 falls on or before Great and Holy Pascha, the Feast of Agios Georgios is commemorated on Easter Monday.

Investors in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) had a good week, as its shares rose 9.7% to close at US$34.54 ...

Q1 2024 Earnings Call Transcript May 2, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge ...

Revenue: US$8.19m (up 46% from 1Q 2023). Net loss: US$81.5m (flat on 1Q 2023). US$1.45 loss per share. All figures shown in ...

AGIO stock results show that Agios Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for ...

Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $81.5 million in its first quarter. The Cambridge, Massachusetts-based company said it had a loss of $1.45 per share. The results ...

In a nutshell, Agios Pharmaceuticals Inc (AGIO) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...